Navigation Links
Youth's social problems contribute to anxiety and depression
Date:3/24/2008

Socially successful children tend to have fewer symptoms of anxiety or depression, while children with problems such as anxiety and depression tend to have difficulties forming relationships and being accepted by friends. However, it is difficult to determine whether the anxiety and depression lead to the social problems, or vice versa. New research suggests that social problems are more likely to contribute to anxiety and depression than the reverse. The research also shows that this is particularly likely during the transition from adolescence into young adulthood.

The study, conducted by researchers at the University of Vermont and the University of Minnesota, appears in the March/April 2008 issue of the journal Child Development.

Using data from Project Competence, which has followed a group of 205 individuals from middle childhood (ages 8 to 12) over 20 years into young adulthood, the researchers used detailed interviews with participants and reports from their parents, teachers, and classmates to create measures of so-called internalizing problems (anxiety, depressed mood, being withdrawn) and social competence (how well one functions in relation to other people, particularly with respect to getting along with others and forming close relationships). They then examined how these measures related to each other over time, taking into account the stability of each (in other words, that children who have social problems at the start of the study may continue to have them over time).

The researchers found that young people who had more internalizing problems (such as anxiety and depression) at the start of the study were more likely to have those problems in adolescence and young adulthood. Those who were socially competent at the start of the study were socially competent as they grew up. However, in addition to this evidence of continuity, the study found evidence of spillover effects, where social problems contributed to incre
'/>"/>

Contact: Andrea Browning
abrowning@srcd.org
202-289-7905
Society for Research in Child Development
Source:Eurekalert

Page: 1 2

Related medicine news :

1. Choking Game Turned Deadly for 82 Youths
2. Texas Youths Named National Epilepsy Spokespersons
3. Wisconsin Youths Named National Epilepsy Spokespersons
4. Dow Jones Sustainability Index Again Recognizes Abbott for Continued Leadership in Business, Environmental and Social Performance
5. Cognitive Activities Protect Against Alzheimers -- Social and Physical Activities Not Enough
6. MJGC Welcomes New Director of Social Work Alla Lerner
7. Civil Rights and Medical Leaders Call for Social Justice in Health Care
8. Multicountry review shows that Bug Buster Kits reduce head lice and social stigma
9. Hartford Foundation awards grant to address geriatric social work shortage
10. Study to consider social risk in guiding prevention of heart disease
11. IOM advisory: improving cancer patients psychosocial care
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/8/2008)...aser scalpels, arthroscopic,surgery, genomic resea...rinary medicine is quickly expanding into new high...e benefit; it,s improving medicine for,people, too... care for their pets to,treat diseases like diabet... according to the American Veterinary Medical Asso...
(Date:9/8/2008)...zine examines Iraq and Afghanistan veterans, strug..., Washington, DC (PRWEB) S...by veterans of the Iraq and Afghanistan wars about... addiction disorders are featured in the current i...ublication of the National Council for Community B...
(Date:9/7/2008)...f older patients successfully treated for colorect...le to detect any recurrence of cancer. The study, ... , a peer-reviewed journal of the American Cancer ...monitoring of colorectal cancer survivors could af...y curative surgery for colorectal cancer have an i...
(Date:9/7/2008)... appear to lower a man,s PSA level, the blood biom...her a man is at risk of prostate cancer. , But t.... 8 in the journal Cancer , caution that men shou... prostate cancer just yet. , "We showed that me...rin and other non-steroidal anti-inflammatory drug...
Breaking Medicine News(10 mins):Health News:High-Tech Vet Medicine Saving Lives of Pets and People 2Health News:Helping Veterans in Our Communities 2Health News:Helping Veterans in Our Communities 3Health News:Many colorectal cancer survivors do not receive recommended follow-up care 2Health News:Common painkillers lower levels of prostate cancer biomarker 2
...min D supplements may help to reduce the risk of h...e 65 who took the supplements had nearly one-third... of certain forms of vitamin D have been associate....// But the positive impact of taking vitamin D su...
...rding to findings of a new report, the risks injec...tis C virus (HCV) from sharing commonly used drug ...ookers" and cotton filters.// While many anti-drug...of sharing hypodermic needles, the new study found...
...positive children ill with measles may get a tempo...ls of HIV are suppressed while measles infection r...findings, because we expected to see HIV replicati...liam Moss, who led the study, said. He said measle...
...ontin is a controlled substance in the United Stat... cancer patients and others. The pill is designed ..., to control the dosage of the powerful narcotic./... and sniffed, it gives a stronger dose--providing ...
Other Medicine News:Health News:Sharing injection equipment spreads Hepatitis C 2
(Date:9/4/2008)...tion for Targeted Therapies That Ensu...N BEACH, Calif., and AMSTERDAM, Netherlands, Sept....cular cancer diagnostics,today announced the laun...llows physicians to quantitatively determine the g...), progesterone receptor (PR) and Human Epidermal,...
(Date:9/3/2008)...irstCall/ -- Simcere,Pharmaceutical Group (NYSE: ...ded generic pharmaceuticals and manufacturer of th...known as Endostar) in China,announced the interim... request of the SFDA, Simcere initiated a Phase IV... therapeutic efficacy of Endu, a modified,version ...
(Date:9/3/2008)... /- Artelis SA and,Selexis SA announc...ntibody,production with the achievement of manufac...ord level was accomplished by applying two highly,...able Selexis CHO,production cell line rapidly gene... using their proprietary Selexis Genetic Elements(...
(Date:9/3/2008)...ingo Launch Progress and Adlea ...ence Call Today at 11:30 am ET, SOUTH SAN FRANCIS...iva,Inc. (Nasdaq: ANSV ) announced today that th...commercial and late-stage product development to,a...ical pain management,company. The company also pro...
Breaking Medicine Technology:Agendia Launches TargetPrint(R) for Breast Cancer Patients 2Simcere Pharmaceutical Group Announces Interim Results of Endu Phase IV Clinical Study 2Simcere Pharmaceutical Group Announces Interim Results of Endu Phase IV Clinical Study 3Artelis and Selexis Report Record Antibody Production Levels in CHO Cells of Over 31 Grams Per Liter 2Artelis and Selexis Report Record Antibody Production Levels in CHO Cells of Over 31 Grams Per Liter 3Anesiva Accelerates Its Transition to Specialty Pharma Pain Management Company 2Anesiva Accelerates Its Transition to Specialty Pharma Pain Management Company 3Anesiva Accelerates Its Transition to Specialty Pharma Pain Management Company 4Anesiva Accelerates Its Transition to Specialty Pharma Pain Management Company 5Iowa State researcher studies how enzymes break down cellulose 2066 1Iowa State researcher studies how enzymes break down cellulose 2066 2American College of Preventive Medicine calls on ABC to cancel Eli Stone episode 10551 1SAFC Pharma Expands Its Pharmorphix Solid State Chemistry Services 10547 1SAFC Pharma Expands Its Pharmorphix Solid State Chemistry Services 10547 2SAFC Pharma Expands Its Pharmorphix Solid State Chemistry Services 10547 3Drug Related Images Trigger Brains Reward Center 10545 1Drug Related Images Trigger Brains Reward Center 10545 2
...26, 2007 /PRNewswire-FirstCall/ --,Replidyne, Inc....,studying REP8839, a novel topical antibiotic that...skin pathogens including,methicillin-resistant S. ...how that topically applied REP8839 appears safe,w...osure, or drug,absorption into the bloodstream, wh...
...-Jun 25, 2007 - New data from an,investigational s...,(ADA) 67th Annual Scientific Sessions showed that...agliptin) and metformin,demonstrated significant i...ients with type 2 diabetes. Pancreatic islet beta,...o produce,insulin, a hormone which plays a central...
Other Medicine Technology:Replidyne Announces Positive Phase I Results for Topical Antibiotic,REP8839 2Replidyne Announces Positive Phase I Results for Topical Antibiotic,REP8839 3Replidyne Announces Positive Phase I Results for Topical Antibiotic,REP8839 4An Investigational Study Released at ADA Showed that Initial,Combination Therapy with Januvia (sitagliptin) and Metformin Led to,Improvement in Markers of Beta Cell Function in Patients with Type,2 Diabetes 2An Investigational Study Released at ADA Showed that Initial,Combination Therapy with Januvia (sitagliptin) and Metformin Led to,Improvement in Markers of Beta Cell Function in Patients with Type,2 Diabetes 3An Investigational Study Released at ADA Showed that Initial,Combination Therapy with Januvia (sitagliptin) and Metformin Led to,Improvement in Markers of Beta Cell Function in Patients with Type,2 Diabetes 4An Investigational Study Released at ADA Showed that Initial,Combination Therapy with Januvia (sitagliptin) and Metformin Led to,Improvement in Markers of Beta Cell Function in Patients with Type,2 Diabetes 5An Investigational Study Released at ADA Showed that Initial,Combination Therapy with Januvia (sitagliptin) and Metformin Led to,Improvement in Markers of Beta Cell Function in Patients with Type,2 Diabetes 6An Investigational Study Released at ADA Showed that Initial,Combination Therapy with Januvia (sitagliptin) and Metformin Led to,Improvement in Markers of Beta Cell Function in Patients with Type,2 Diabetes 7An Investigational Study Released at ADA Showed that Initial,Combination Therapy with Januvia (sitagliptin) and Metformin Led to,Improvement in Markers of Beta Cell Function in Patients with Type,2 Diabetes 8An Investigational Study Released at ADA Showed that Initial,Combination Therapy with Januvia (sitagliptin) and Metformin Led to,Improvement in Markers of Beta Cell Function in Patients with Type,2 Diabetes 9An Investigational Study Released at ADA Showed that Initial,Combination Therapy with Januvia (sitagliptin) and Metformin Led to,Improvement in Markers of Beta Cell Function in Patients with Type,2 Diabetes 10An Investigational Study Released at ADA Showed that Initial,Combination Therapy with Januvia (sitagliptin) and Metformin Led to,Improvement in Markers of Beta Cell Function in Patients with Type,2 Diabetes 11An Investigational Study Released at ADA Showed that Initial,Combination Therapy with Januvia (sitagliptin) and Metformin Led to,Improvement in Markers of Beta Cell Function in Patients with Type,2 Diabetes 12An Investigational Study Released at ADA Showed that Initial,Combination Therapy with Januvia (sitagliptin) and Metformin Led to,Improvement in Markers of Beta Cell Function in Patients with Type,2 Diabetes 13An Investigational Study Released at ADA Showed that Initial,Combination Therapy with Januvia (sitagliptin) and Metformin Led to,Improvement in Markers of Beta Cell Function in Patients with Type,2 Diabetes 14An Investigational Study Released at ADA Showed that Initial,Combination Therapy with Januvia (sitagliptin) and Metformin Led to,Improvement in Markers of Beta Cell Function in Patients with Type,2 Diabetes 15An Investigational Study Released at ADA Showed that Initial,Combination Therapy with Januvia (sitagliptin) and Metformin Led to,Improvement in Markers of Beta Cell Function in Patients with Type,2 Diabetes 16An Investigational Study Released at ADA Showed that Initial,Combination Therapy with Januvia (sitagliptin) and Metformin Led to,Improvement in Markers of Beta Cell Function in Patients with Type,2 Diabetes 17An Investigational Study Released at ADA Showed that Initial,Combination Therapy with Januvia (sitagliptin) and Metformin Led to,Improvement in Markers of Beta Cell Function in Patients with Type,2 Diabetes 18An Investigational Study Released at ADA Showed that Initial,Combination Therapy with Januvia (sitagliptin) and Metformin Led to,Improvement in Markers of Beta Cell Function in Patients with Type,2 Diabetes 19An Investigational Study Released at ADA Showed that Initial,Combination Therapy with Januvia (sitagliptin) and Metformin Led to,Improvement in Markers of Beta Cell Function in Patients with Type,2 Diabetes 20An Investigational Study Released at ADA Showed that Initial,Combination Therapy with Januvia (sitagliptin) and Metformin Led to,Improvement in Markers of Beta Cell Function in Patients with Type,2 Diabetes 21An Investigational Study Released at ADA Showed that Initial,Combination Therapy with Januvia (sitagliptin) and Metformin Led to,Improvement in Markers of Beta Cell Function in Patients with Type,2 Diabetes 22An Investigational Study Released at ADA Showed that Initial,Combination Therapy with Januvia (sitagliptin) and Metformin Led to,Improvement in Markers of Beta Cell Function in Patients with Type,2 Diabetes 23An Investigational Study Released at ADA Showed that Initial,Combination Therapy with Januvia (sitagliptin) and Metformin Led to,Improvement in Markers of Beta Cell Function in Patients with Type,2 Diabetes 24An Investigational Study Released at ADA Showed that Initial,Combination Therapy with Januvia (sitagliptin) and Metformin Led to,Improvement in Markers of Beta Cell Function in Patients with Type,2 Diabetes 25An Investigational Study Released at ADA Showed that Initial,Combination Therapy with Januvia (sitagliptin) and Metformin Led to,Improvement in Markers of Beta Cell Function in Patients with Type,2 Diabetes 26An Investigational Study Released at ADA Showed that Initial,Combination Therapy with Januvia (sitagliptin) and Metformin Led to,Improvement in Markers of Beta Cell Function in Patients with Type,2 Diabetes 27An Investigational Study Released at ADA Showed that Initial,Combination Therapy with Januvia (sitagliptin) and Metformin Led to,Improvement in Markers of Beta Cell Function in Patients with Type,2 Diabetes 28An Investigational Study Released at ADA Showed that Initial,Combination Therapy with Januvia (sitagliptin) and Metformin Led to,Improvement in Markers of Beta Cell Function in Patients with Type,2 Diabetes 29An Investigational Study Released at ADA Showed that Initial,Combination Therapy with Januvia (sitagliptin) and Metformin Led to,Improvement in Markers of Beta Cell Function in Patients with Type,2 Diabetes 30An Investigational Study Released at ADA Showed that Initial,Combination Therapy with Januvia (sitagliptin) and Metformin Led to,Improvement in Markers of Beta Cell Function in Patients with Type,2 Diabetes 31An Investigational Study Released at ADA Showed that Initial,Combination Therapy with Januvia (sitagliptin) and Metformin Led to,Improvement in Markers of Beta Cell Function in Patients with Type,2 Diabetes 32
The Explorer 360 and 360 Jr. catheters have a rotational connector for ease of use during procedures.
...of the PARAHISIAN catheter, combines an octapolar ...es, which permits the use of only one catheter for...is bundle electrograms. The "two catheters in one"...single venipuncture. The disadvantages of using tw...
Torqr Quadripolar Braided Shaft Fixed Curve. The Medtronic CardioRhythm Torqr Catheter is intended for use in diagnostic electrophysiologic procedures. The catheter is designed for recording intrac
Xtrem Dynamic is a line of steerable diagnosis catheters with micro handle. These catheters have been designed to provide pacing and recording during invasive electrophysiology procedures.
Medicine Products: